Post job

Adaptive Biotechnologies overview

Industry
Biotechnology
Revenue
Headquarters
Employees
858
Founded in
Website
Organization type
Public
Social media
Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Founded in 2009, Adaptive Biotechnologies is an established company that loves to hire graduates from Washington State University, with 14.3% of its employees having attended Washington State University. Want to compare Adaptive Biotechnologies to some other great places to work in Seattle, WA? We suggest taking a look at Zippia's list of Best Companies to Work For in Seattle, WA.
Adaptive Biotechnologies is a medium health care company with 858 employees and an annual revenue of $179.0M that is headquartered in Seattle, WA.

Adaptive Biotechnologies's mission statement

To transforming the diagnosis and treatment of immune-mediated diseases including cancer, autoimmune disorders, and infectious disease through ground-breaking immunosequencing applications.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Adaptive Biotechnologies employee reviews

Be the first to review!

Do you work at Adaptive Biotechnologies?

Help job seekers learn about working at Adaptive Biotechnologies

Job openings at Adaptive Biotechnologies
14 positions

On this page

Be the first to review Adaptive Biotechnologies

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Adaptive Biotechnologies?

The team at Adaptive Biotechnologies

  • The founders of Adaptive Biotechnologies are Chad Robins, Harlan Robins, Christopher Carlson and Wayne Bellett.
  • The key people at Adaptive Biotechnologies are Chad Robins, Harlan Robins and Christopher Carlson.
Key people
Chad Robins
Harlan Robins
Christopher Carlson
Wayne Bellett

Adaptive Biotechnologies salaries

Average Adaptive Biotechnologies salary
$84,026
yearly
$40.40 hourly
Updated March 14, 2024

Rate Adaptive Biotechnologies' promotion and raise policies.

Zippia waving zebra

Do you work at Adaptive Biotechnologies?

Did Adaptive Biotechnologies' compensation package meet your expectations?

Adaptive Biotechnologies financial performance

7.9
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Adaptive Biotechnologies currently has 185.3M in revenue. Adaptive Biotechnologies's most recent quarter produced 48.9m (q2'2023).

Adaptive Biotechnologies annual revenue

$185M
$148M
$111M
$74M
$37M
$0
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at Adaptive Biotechnologies?

Claiming and updating your company profile on Zippia is free and easy.

Adaptive Biotechnologies FAQs

Search for jobs

Most common locations at Adaptive Biotechnologies

Most common jobs at Adaptive Biotechnologies

Zippia gives an in-depth look into the details of Adaptive Biotechnologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Adaptive Biotechnologies. The employee data is based on information from people who have self-reported their past or current employments at Adaptive Biotechnologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Adaptive Biotechnologies. The data presented on this page does not represent the view of Adaptive Biotechnologies and its employees or that of Zippia.

Adaptive Biotechnologies may also be known as or be related to ADAPTIVE BIOTECHNOLOGIES CORP, Adaptive Biotechnologies, Adaptive Biotechnologies Corp, Adaptive Biotechnologies Corp. and Adaptive Biotechnologies Corporation.